U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3744137441Effect of LAPS-Exendin on Body Weight in Obese PopulationNot yet recruitingNo Results AvailableObesityBiological: HM11260C|Biological: Placebohttps://ClinicalTrials.gov/show/NCT02075281
3744237442Clinical Trial to Characterize Pharmacokinetic-pharmacodynamic (PKPD) of Prasugrel 10 mg or 30 mg in Healthy VolunteersRecruitingNo Results AvailableHealthyDrug: prasugrelhttps://ClinicalTrials.gov/show/NCT02075268
3744337443Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS TherapyRecruitingNo Results AvailableAsthmaBiological: Benralizumab|Biological: Placebo|Biological: Benralizumabhttps://ClinicalTrials.gov/show/NCT02075255
3744437444TO Compare the Triple Drug Therapy and Dual Therapy .RecruitingNo Results AvailableHEPATITISDrug: Mycophenolate Mofetil|Drug: Tacrolimushttps://ClinicalTrials.gov/show/NCT02075242
3744537445Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS PopulationRecruitingNo Results AvailableBilateral Sensorineural Hearing LossDevice: Cochlear implanthttps://ClinicalTrials.gov/show/NCT02075229
3744637446Transurethral Myoblast Injection for Urinary Incontinence in Children With Bladder ExstrophyRecruitingNo Results AvailableUrinary IncontinenceProcedure: Myoblast Transplantation|Biological: Neonatal Cystourethroscope Injectionhttps://ClinicalTrials.gov/show/NCT02075216
3744737447A Randomized, Placebo Controlled, Partially Blinded Phase II Study to Evaluate Safety, Immunogenicity, and Prevention of Infection With Mycobacterium Tuberculosis of AERAS-404 and BCG Revaccination in Healthy Adolescents (040-404)Active, not recruitingNo Results AvailableTuberculosisBiological: AERAS-404|Drug: Placebo|Biological: Bacillus Calmette-Guérin (BCG)https://ClinicalTrials.gov/show/NCT02075203
3744837448Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in DepressionRecruitingNo Results AvailableCognitive-affective Exercises|Engaging ExercisesOther: Computerized interventionhttps://ClinicalTrials.gov/show/NCT02075190
3744937449Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in NeuroblastomaAvailableNo Results AvailableRecurrent Neuroblastoma|NeuroblastomaDrug: Fenretinide Lym-X-Sorb Oral Powder|Drug: Ketoconazolehttps://ClinicalTrials.gov/show/NCT02075177
3745037450Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLDRecruitingNo Results AvailableNon-alcoholic Fatty Liver Disease|Non-alcoholic SteatohepatitisDietary Supplement: Fructose|Dietary Supplement: Glucosehttps://ClinicalTrials.gov/show/NCT02075164
3745137451Bronchial Thermoplasty: Mechanism of Action and Defining Asthma PhenotypeNot yet recruitingNo Results AvailableAsthmaProcedure: Bronchial Thermoplastyhttps://ClinicalTrials.gov/show/NCT02075151
3745237452Grass Observational StudyCompletedNo Results AvailableGrass Allergy|Rhinoconjunctivitishttps://ClinicalTrials.gov/show/NCT02075138
3745337453Prasugrel and Ticagrelor in ST-segment Elevation Myocardial InfarctionTerminatedNo Results AvailableST-Segment Elevation Myocardial InfarctionDrug: Prasugrel 60 mg|Drug: Ticagrelor 180 mghttps://ClinicalTrials.gov/show/NCT02075125
3745437454Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and NeckActive, not recruitingNo Results AvailableCancer of Head and NeckDrug: Soy isoflavone|Radiation: Radiation|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT02075112
3745537455Evaluation of the Efficiency of Hydration by Isotonic Solution in the Prevent of the Fainting Whole Blood DonorsCompletedNo Results AvailableFainting|Presyncope|Syncopal EpisodeOther: tensing exercises|Other: No tensing exerciseshttps://ClinicalTrials.gov/show/NCT02075099
3745637456Angiogenic Switch in Patients With Colorectal CancerActive, not recruitingNo Results AvailableColorectal CancerDrug: Xelox or Xeliri Bevacizumabhttps://ClinicalTrials.gov/show/NCT02075086
3745737457Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male SubjectsCompletedNo Results AvailableHealthyBiological: SB3|Biological: EU sourced Herceptin®|Biological: US sourced Herceptin®https://ClinicalTrials.gov/show/NCT02075073
3745837458Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder CancerRecruitingNo Results AvailableNon Muscle-invasive Bladder CancerProcedure: IPOI (pre-operative)|Procedure: IPOP (post-operative)https://ClinicalTrials.gov/show/NCT02075060
3745937459Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I DisorderRecruitingNo Results AvailableBipolar DisorderDrug: placebo oral capsules|Drug: ziprasidone oral capsuleshttps://ClinicalTrials.gov/show/NCT02075047
3746037460Three Dosing Schedules of Oral Rigosertib in MDS PatientsSuspendedNo Results AvailableMyelodysplastic SyndromeDrug: rigosertibhttps://ClinicalTrials.gov/show/NCT02075034
3746137461Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple MyelomaRecruitingNo Results AvailableRelapsed or Refractory Multiple MyelomaDrug: Lenalidomide|Drug: nab-paclitaxelhttps://ClinicalTrials.gov/show/NCT02075021
3746237462Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201RecruitingNo Results AvailableAsthmaDrug: QGE031https://ClinicalTrials.gov/show/NCT02075008
3746337463Study of Tolerability and Efficacy of BVS857 in Severe Burn SubjectsCompletedNo Results AvailableHypercatabolic Status Related to Severe BurnBiological: BVS857|Other: placebohttps://ClinicalTrials.gov/show/NCT02074995
3746437464Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisActive, not recruitingNo Results AvailableChronic Plaque Type PsoriasisDrug: secukinumab 300 mg|Drug: ustekinumab 45/90 mg sc and placebo secukinumabhttps://ClinicalTrials.gov/show/NCT02074982
3746537465Intramedullary Devices for the Treatment of Unstable Pertrochanteric FracturesCompletedNo Results AvailableFracturesDevice: Gamma Nail 3|Device: PFNAhttps://ClinicalTrials.gov/show/NCT02074969
3746637466A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in AdultsCompletedNo Results AvailableTuberculosisBiological: AERAS-404|Biological: Placebohttps://ClinicalTrials.gov/show/NCT02074956
3746737467Efficacy and Safety of Platelet Rich Plasma in Androgenetic AlopeciaRecruitingNo Results AvailableAndrogenetic AlopeciaBiological: PRPhttps://ClinicalTrials.gov/show/NCT02074943
3746837468Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen ExposureCompletedNo Results AvailableBirch Pollen AllergyDevice: Microporation by P.L.E.A.S.E. Professional / Prick needlehttps://ClinicalTrials.gov/show/NCT02074930
3746937469Comparison of Dynamic Knee Stability and Functional Outcomes in Anatomical ACL Reconstruction at AM or Central PositionRecruitingNo Results AvailableRupture of Anterior Cruciate Ligament|Complete Tear, Knee, Anterior Cruciate LigamentProcedure: Anatomical ACL reconstructionhttps://ClinicalTrials.gov/show/NCT02074917
3747037470Topiramate's Effects on Heavy DrinkingNot yet recruitingNo Results AvailableAlcohol DrinkingDrug: Topiramate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02074904

* Görseller ve İçerik tekif hakkına sahip olabilir